OSTEONICS SPINAL SYSTEM - SACRAL OFFSET CONNECTOR ASSEMBLY

K984375 · Osteonics Corp. · KWP · Apr 30, 1999 · Orthopedic

Device Facts

Record IDK984375
Device NameOSTEONICS SPINAL SYSTEM - SACRAL OFFSET CONNECTOR ASSEMBLY
ApplicantOsteonics Corp.
Product CodeKWP · Orthopedic
Decision DateApr 30, 1999
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3050
Device ClassClass 2
AttributesTherapeutic

Indications for Use

As a posterior, non-pedicle screw system of the T4-S2 spine, the Osteonics® Spinal System is indicated for: Long and short curve scoliosis . Vertebral fracture or dislocation . Spondylolisthesis . Degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies). . Previously failed fusion . Spinal tumor Pedicular Use: When used as a pedicle screw fixation system of the non-cervical posterior spine in skeletally mature patients, the Osteonics Spinal System is indicated for one or more of the following: degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis). In addition, the Osteonics Spinal system is indicated for pedicle screw fixation in skeletally mature patients with severe spondylolisthesis (Grades 3 and 4) at the L5-S1 joint, having fusions with autogenous bone graft, having the device fixed or attached to the lumbar and sacral spine (with pedicle placement at L3 and below)with removal of the implants after the development of a solid fusion mass.

Device Story

Osteonics Spinal System Sacral Offset Connector Assembly; provides supplemental sacral screw placement; connects sacral screw to spinal rod; includes sacral offset blocker and clamping screw for stable rod locking. Used in spinal surgery; operated by surgeons. Manufactured from titanium alloy; single-use; non-sterile. Facilitates spinal fixation and stabilization; supports fusion procedures.

Clinical Evidence

Bench testing only. No clinical data provided.

Technological Characteristics

Material: ASTM F-136-96 Titanium alloy (Ti6Al4V ELI). Components: Sacral offset connector, sacral offset blocker, clamping screw. Design: Spinal fixation appliance for sacral offset. Single-use, non-sterile.

Indications for Use

Indicated for patients with scoliosis, vertebral fracture/dislocation, spondylolisthesis, degenerative disc disease, failed fusion, or spinal tumor in the T4-S2 spine. Pedicular use indicated for skeletally mature patients with degenerative spondylolisthesis, fracture, dislocation, scoliosis, kyphosis, spinal tumor, or failed fusion. Also indicated for severe spondylolisthesis (Grades 3-4) at L5-S1 in skeletally mature patients requiring fusion with autogenous bone graft.

Regulatory Classification

Identification

A spinal interlaminal fixation orthosis is a device intended to be implanted made of an alloy, such as stainless steel, that consists of various hooks and a posteriorly placed compression or distraction rod. The device is implanted, usually across three adjacent vertebrae, to straighten and immobilize the spine to allow bone grafts to unite and fuse the vertebrae together. The device is used primarily in the treatment of scoliosis (a lateral curvature of the spine), but it also may be used in the treatment of fracture or dislocation of the spine, grades 3 and 4 of spondylolisthesis (a dislocation of the spinal column), and lower back syndrome.

Predicate Devices

Submission Summary (Full Text)

{0}------------------------------------------------ 4/30/99 K984/375 # 510(k) PREMARKET NOTIFICATION SUMMARY OF SAFETY AND EFFECTIVENESS OSTEONICS® SPINAL SYSTEM - SACRAL OFFSET CONNECTOR ASSEMBLY # Submission Information | Name and Address of the Sponsor<br>of the 510(k) Submission: | Osteonics Corporation<br>59 Route 17<br>Allendale, NJ 07401-1677<br>201-825-4900 | |--------------------------------------------------------------|-------------------------------------------------------------------------------------------------------| | Contact Person: | Marybeth Naughton<br>Regulatory Affairs Team Member | | Date Summary Prepared: | December 4, 1998 | | Device Identification | | | Proprietary Name: | Osteonics® Spinal System -Sacral Offset<br>Connector Assembly | | Common Name: | Spinal Fixation Appliances | | Classification Name and Reference: | Spinal Interlaminal Fixation Orthosis<br>21 CFR §888.3050<br>Pedicle Screw System<br>21 CFR §888.0370 | #### Predicate Device Identification The Osteonics® Spinal System Sacral Offset Connector Assembly components are substantially equivalent to other legally marketed spinal system sacral offset components. These predicate components are part of the commercially available spinal systems stated below: - Tacoma™ Sacral Plate System: Sofamor Danek . - Saddle with Anchor™ Fixation System: Advanced Spine Fixation Systems, Inc. . #### Device Description The Osteonics® Spinal System is comprised of single use, non-sterile devices manufactured from ASTM F-136-96 Titanium alloy (Ti6A1-4V ELI). The Osteonics® Spinal System Sacral Offset Connector Assembly may be used in any application where supplemental sacral screw placement is desired by the surgeon. This assembly allows a sacral connector with supplemental sacral screw to the joined to the spinal rod in the sacral offset blocker secures the sacral screw to the connector assembly. The Clamping Screw is used with the Sacral Offset Connector to provide a stable lock on the longitudinal spinal rod. {1}------------------------------------------------ ## Intended Use The following are specific indications for the Osteonics® Spinal System: ## As a non-pedicle screw system of the T4-S2 spine, the Osteonics® Spinal System is indicated for: - Long and short curve scoliosis . - . Vertebral fracture or dislocation - . Spondylolisthesis - . Degenerative disc disease (defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies). - . Previously failed fusion - . Spinal tumor ## Pedicular Use: - When used as a pedicle screw fixation system of the non-cervical posterior spine in skeletally . mature patients. the Osteonics Spinal System is indicated for one or more of the following: degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, scoliosis, kyphosis, spinal tumor, and failed previous fusion (pseudarthrosis). - In addition, the Osteonics Spinal system is indicated for pedicle screw fixation in skeletally . mature patients with severe spondylolisthesis (Grades 3 and 4) at the LS-S1 joint, having fusions with autogenous bone graft, having the device fixed or attached to the lumbar and sacral spine (with pedicle placement at L3 and below)with removal of the implants after the development of a solid fusion mass. ## Statement of Technological Comparison The components of the Osteonics® Spinal System Sacral Offset Connector Assembly share the same materials, intended uses and basic design concepts as that of the predicate devices. Fatigue and static testing demonstrates the mechanical and endurance properties of these components. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the logo is an abstract symbol that resembles an eagle or a bird in flight, composed of three curved lines. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 APR 3 0 1999 Ms. Marybeth Naughton Regulatory Affairs Team Member Stryker Osteonics 59 Route 17 Allendale, New Jersey 07401-1677 Re: K984375 > Trade Name: Osteonics® Spinal System Sacral Offset Connector Assembly Regulatory Class: II Product Codes: KWP, MNH and MNI Dated: February 24, 1999 Received: February 25, 1999 Dear Ms. Naughton: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {3}------------------------------------------------ This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597, or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Celia M. Witten, Ph.D., M.D. a M. Witten, Ph.D., M.D. - Cel Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ 510(k) Number (if known): K984375 Device Name: Osteonics® Spinal System Indications For Use: The uses for the legally marketed Osteonics® Spinal System are as follows: # As a posterior, non-pedicle screw system of the T4-S2 spine, the Osteonics® Spinal System is indicated for: - Long and short curve scoliosis ● - . Vertebral fracture or dislocation - . Spondylolisthesis - Degenerative disc disease (defined as back pain of discogenic origin with degeneration of . the disc confirmed by history and radiographic studies). - . Previously failed fusion - . Spinal tumor #### Pedicular Use: - When used as a pedicle screw fixation system of the non-cervical posterior spine in . skeletally mature patients, the Osteonics Spinal System is indicated for one or more of the following: degenerative spondylolisthesis with objective evidence of neurological impairment, fracture, dislocation, scoliosis, kyphosis, spinal turnor, and failed previous fusion (pseudarthrosis). - In addition, the Osteonics Spinal system is indicated for pedicle screw fixation in ● skeletally mature patients with severe spondylolisthesis (Grades 3 and 4) at the L5-S1 joint, having fusions with autogenous bone graft, having the device fixed or attached to the lumbar and sacral spine (with pedicle placement at L3 and below)with removal of the implants after the development of a solid fusion mass. # (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (OD e Evaluation (ODE) Division Sign-Off (Division Division of General Rest 510(k) Number Prescription Usex OR Over-The-Counter Use (Optional Format 1-2-96) (Per 21 CFR 801.109)
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...